Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: HighLife Clarity Treatment of Severe Mitral Regurgitation [NA]

View source ↗

Summary

A clinical trial update from HighLife SAS describes the HighLife Clarity treatment for severe mitral valve regurgitation, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HighLife Clarity

Snippet

Sponsor: HighLife SAS | Conditions: Mitral Valve (MV) Regurgitation | NA | Status: NOT_YET_RECRUITING